Niva Bupa Health Insurance IPO Day 1: Check subscription status, GMP, review, and other details

Niva Bupa Health Insurance IPO was subscribed 8% as of 1200 IST on November 07, 2024. The company received bids worth Rs 100.55 crore. Retail investors booked the issue 0.42 times, the highest among other categories. The NIIs subscribed to the IPO 0.02 times. There was no interest shown by the QIBs.

Niva Bupa Health Insurance IPO Details

The health insurance IPO opened on November 07 to raise Rs 2,200 crore. The IPO will close on November 11. The IPO price band ranged between Rs 70 to Rs 74 per equity share. The share allotment will likely be finalised on November 12. The listing on NSE and BSE is expected to be on November 14. An individual retail buyer can apply for a minimum of 200 shares which costs Rs 14,800 and then in multiples of 200 shares. 

Niva Bupa Health Insurance IPO GMP

The company’s shares were neither fetching a premium nor a discount in the grey market, indicating muted listing gains. Market participants keep an eye on GMP to track listing gains. The grey market is an illegal market to trade shares ahead of listing. 

Also ReadSwiggy Vs Niva Bupa Health Insurance: Which IPO should you bet on this week?

Expert’s take on Niva Bupa Health Insurance

“We believe Niva Bupa Health Insurance IPO brings investors an opportunity to invest in one of India’s fastest-growing standalone health insurers with a robust product portfolio, strategic innovation and digital advancements. We think with high-margin, high-LTV products driving significant growth in their retail health business, the company has managed to increase the average ticket size and improve its claims ratio, demonstrating operational efficiency. We also believe recent product launches like “ReAssure” and “Aspire,” aimed at diverse demographics, along with a well-developed “360-degree” health ecosystem on their app, reflect a customer-centric approach with long-term potential,” said  Rajan Shinde, Research Analyst at Mehta Equities.

BRLMs and registrar

ICICI Securities, Morgan Stanley India Company, Kotak Mahindra Capital Company, Axis Capital, HDFC Bank, and Motilal Oswal Investment Advisors are the book-running lead managers of the IPO. Kfin Technologies was the registrar for the issue.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations